ASX Share rice
Fri 14 Aug 2020 - 05:20:pm (Sydney)

SUD Share Price

SUDA PHARMACEUTICALS LTDSUDPharmaceuticals, Biotechnology & Life Sciences

SUD Company Information

Name:

Suda Pharmaceuticals Ltd

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

55 Howe Street Osborne Park Australia 6017

Phone:

61 8 6142 5555

CFO & Joint Company Sec.:

Mr. Joseph Daniel Ohayon

Chief Technical Officer:

Dr. Carol Worth

Consultant:

Mr. Stephen John Carter

Exec. Director:

Mr. David Phillips

CEO, MD & Director:

Dr. Michael Baker

Company Overview:

Suda Pharmaceuticals Ltd engages in the development of drug delivery technology in Australia. Its product pipeline includes ZolpiMist, a oro-mucosal spray formulation of zolpidem tartrate marketed under the brand name of Ambien or Stilnox, a non-benzodiazepine prescribed for the short-term treatment of insomnia; ArTiMist, a sub-lingual spray for the treatment of p. falciparum severe paediatric malaria; and Midazolam, a flavoured oral spray formulation for the treatment of epileptic seizures and pre-procedure anxiety in imaging and dental procedures under the Versed brand. The company's product pipeline also comprises Sumatriptan, an oral spray formulation for the treatment of acute migraine; Ondansetron, a mint-flavored oral spray formulation for the treatment of chemotherapy induced nausea and vomiting and postoperative nausea and vomiting; Sildenafil, an oral spray formulation for the treatment of erectile dysfunction. Suda Pharmaceuticals Ltd has license and supply agreement with Teva Pharmaceuticals International GmbH for ZolpiMist oral spray; and feasibility and option agreement with Zelda Therapeutics Ltd for the use of cannabinoids for a range of uses, including insomnia, autism, opioid reduction, anxiety, pain and cancer. The company also has a feasibility study and option agreement with Laboratorios Ordesa, S.L. to co-develop a consumer product for the pediatric market. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.

SUD Share Price Information

Shares Issued:

305.85M

Market Capitalisation:

$11.93M

Revenue (TTM):

$779.36K

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.003

Operating Margin (TTM):

$-4.87

Return On Assets (TTM):

$-0.17

Return On Equity (TTM):

$-1.25

Quarterly Revenue Growth (YOY):

-0.552

Gross Profit(TTM):

$1.03M

Diluted Earnings Per Share (TTM):

$-0.12

SUD CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-1,384,318

Change To Liabilities:

$-1,356,981

Total Cashflow From Investing Activities:

$-1,384,318

Net Income:

$-7,795,039

Total Cash From Operating Activities:

$-2,495,488

Depreciation:

$121.72K

Change To Inventory:

$52.56K

Change To Account Receivables:

$-330,136

Capital Expenditures:

$1.38M

SUD Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-8,720,039

Net Income:

$-7,795,039

Gross Profit:

$1.02M

Operating Income:

$-2,355,718

Other Operating Expenses:

$1.55M

Interest Expense:

$125.06K

Income Tax Expense:

$-925,000

Total Revenue:

$1.22M

Total Operating Expenses:

$3.38M

Cost Of Revenue:

$199.69K

SUD Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$10.29M

Total Liabilities:

$2.28M

Total Stockholder Equity:

$13.98M

Other Current Liabilities:

$800.78K

Total Assets:

$16.25M

Common Stock:

$67.39M

Other Current Assets:

$115.28K

Retained Earnings:

$-55,711,877

Other Liabilities:

$0.91M

Other Assets:

$10.16M

Cash:

$4.31M

Total Current Liabilities:

$1.35M

Short-Term Debt:

$36.21K

Property - Plant & Equipment:

$367.37K

Net Tangible Assets:

$13.85M

Total Current Assets:

$5.60M

Long-Term Debt:

$16.91K

Net Receivables:

$293.64K

Short-Term Investments:

$10.66M

Inventory:

$45.41K

Accounts Payable:

$511.58K

Non Currrent Assets (Other):

$10.66M

Short-Term Investments:

$10.66

Non Current Liabilities Total:

$0.93M

SUD Share Price History

SUD News

28 Apr, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
23 Jan, 2020
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. For example, we sympathize with...
18 Oct, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...